C4 Therapeutics (CCCC)
(Delayed Data from NSDQ)
$6.35 USD
-0.22 (-3.35%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $6.36 +0.01 (0.16%) 6:48 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: -- |
9/2024 | $-0.40 | 0.00% |
Earnings Summary
For their last quarter, C4 Therapeutics (CCCC) reported earnings of -$0.26 per share, beating the Zacks Consensus Estimate of $-0.37 per share. This reflects a positive earnings surprise of 29.73%. Look out for CCCC's next earnings release expected on November 06, 2024. For the next earning release, we expect the company to report earnings of -$0.40 per share, reflecting a year-over-year increase of 27.27%.
Earnings History
Price & Consensus
Zacks News for CCCC
Community Health Systems (CYH) Reports Q2 Loss, Tops Revenue Estimates
CCCC: What are Zacks experts saying now?
Zacks Private Portfolio Services